Dr. Dheeraj Khurana

Dr. Dheeraj Khurana
Neurologist, Chandigarh

MBBS, MD (Med), DM (Neurology)

  • 1 Hospital


  • Neurology


  • Neurosonology: Carotid duplex, TCD monitoring and therapeutic TCD
  • Acute Stroke: thrombolysis, Neuroimaging.
  • Multiple Sclerosis: Management
  • Neurotoxicology:  Organophosphorus  Intoxication


MBBS, 1991, DMCH, Ludhiana, India

MD (Med), 1996, DMCH, Ludhiana, India

DM (Neurology), 2000, PGIMER, Chandigarh, India

Practice Information

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Dheeraj Khurana and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • INTERSTROKE - Importance of Conventional and Emerging Risk Factors for Stroke : A Case Control study Closed (Apr 2014) NIH, USA (SJRI, Bangalore)
  • SITS SEARES – Safe Implementation of Treatments in Stroke Ongoing
  • Indo-US Collaborative stroke Registry and Infrastucture development (US-India Bilateral brain research Collaborative partnerships) Ongoing DBT, India
  • ATTEND- Family- Led rehabilitation after stroke in India -The ATTEND trial (PI) OngoingGeorge Institute, Hyderabad.
  • MSBase: An International Registry dedicated to evaluating outcomes data in Multiple Sclerosis (MS), an electronic multiple sclerosis patient clinical database.
  • Gupta RK, Bapuraj JR, Khandelwal N, Khurana D. Prognostic indices for cerebral venous thrombosis on CT perfusion: a prospective study. Eur J Radiol. 2014 Jan; 83(1) : 185-90.
  • Kesav P, Vishnu VY, Sharma A, Khurana D. False-positive 'cord sign'. BMJ Case Rep. 2013 Apr 23; 2013.
  • Kesav P, Khurana D, Bhadada S, Nada R, Das A, Lal V. Multiple endocrine neoplasia type I presenting as recurrent stroke like episodes. Clin Neurol Neurosurg. 2013 Sep; 115(9) : 1914-6.
  • Kesav P, Vishnu VY, Khurana D. Is neurobrucellosis the Pandora's Box of modern medicine? Clin Infect Dis. 2013 Oct; 57(7) : 1056-7.
  •  Khurana D, Mathur D, Prabhakar S, Thakur K, Anand A. Vascular endothelial growth factor (VEGF) and monocyte chemoattractant protein-1 (MCP-1) levels unaltered in symptomatic atherosclerotic carotid plaque patients from north India. Frontiers in Neurology 2013; 4 : 27.doi:10.3389.
  • Khurana D, Kumari B, Rajan R, Ahuja C, Vyas S. Efficacy and safety ofthrombolysis in patients aged 80 or more with major ischemic stroke: specialreference to nonagenarians. Neurol India. 2012 Nov-Dec;60(6):686-7.
  • Kesav P, Vy V, Khurana D. A reversible cause of coma in epilepsy. BMJ CaseRep. 2012 Dec 13;2012.
  • Member - American Academy of Neurology
  • Professional Member ¨C American Stroke Association
  • Member ¨C European Stroke Organisation
  • Member- World Stroke Organisation
  • Member - European Atherosclerosis Society
  • Life Member- Indian Stroke Association
  • Life Member of the Indian Academy of Neurology (IAN)
  • Life Member of the Neurological Society of India (NSI)